Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

In This Section

Courses Quicksearch

Fill out one or more of the fields to search for courses

Search Now!

Courses

Considerations in Nursing

Mary Bartlett

Melisa Wilson


Beth Coleman

Arlene Schiro


Janet Pinson


0 comments
Leave a Comment

Course ID: 2151

This course features 3 sessions from the 2011 PH Professional Network Symposium that focus on issues of special interest to nurses. These topics include the art of patient interviewing, transitions in treatment and the importance of a strong treatment algorithm. This course is offered for a maximum of 3.0 hours of nursing CEUs.

Course Authors

Transitions in Therapy: Integrating Best Practices

Diahann K. Wilcox, APRN, University of Connecticut Health Center
Traci Housten, RN, MS, Johns Hopkins Pulmonary Hypertension Program
Steve Walker, MS, CRNP, The Children's Hospital of Philadelphia

Asking the Right Questions: The Lost Art of Patient Interviewing

Janet M. Pinson, NP, VCU Health System
Arlene G. Schiro, MA, ACNP-BC, Brigham and Women's Hospital
Beth A. Coleman, RN, MSN, CPNP-PC, Children's Hospital Colorado

A PAH Treatment Algorithm: The Power of a Solid Plan

Melisa Wilson, APRN, BC, Orlando Heart Center
Mary Bartlett, MS, RN, CS, FNP, Winthrop University Hospital

Learning Objectives

Upon successful completion of this course, participants will be able to:

  1. Identify indications for transitioning between prostacyclins
  2. Discuss criteria which may indicate transitioning is safe to attempt
  3. Identify relative and absolute contraindications to transitions
  4. Review relevant case experiences/protocols with transitioning
  5. Develop a repertoire of key questions that differentiates PAH from pulmonary hypertension
  6. Learn how to use the "Walmart test" to assess WHO functional class
  7. Discover how to interview a PAH patient while alleviating their anxiety
  8. Construct ways to creatively obtain a good history from a pediatric patient
  9. Illustrate the current evidence-based PAH treatment algorithms
  10. Utilize the evidence-based PAH algorithms to determine the appropriateness of therapy for specific PAH patients
  11. Create a PAH treatment regimen with consideration of a patient's psychosocial status, social support, and quality of life

Release Date:

31 May 2012

Expiration Date:

31 May 2014 

Accreditation and Credit Designation

Nursing credit is provided through collaboration between ProCE, Inc., Wild Iris Medical Education, Inc., and the Pulmonary Hypertension Association. Wild Iris Medical Education, Inc. is an approved provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 3.0 contact hour of nursing CE credit.

Instructions for Earning Credit

This activity is a self-study program. Upon entering the activity, participants should read the text, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be asked to complete a post-test and evaluation online. Participants must receive a test score of 100% in order to proceed to the course evaluation; the post-test can be repeated until all questions are answered correctly. All evaluation questions must be completed in order to receive a certificate of credit. If needed, participants may save their answers and complete the course at a later date. Saved courses can be found by using the "My Courses" link at the top of the page, and then click on "My Classes".

Faculty Disclosures

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation.
Mary Bartlett, MS, RN, CS, FNP, indicates no financial relationship to disclose
Melisa Wilson, APRN, BC, indicates no financial relationship to disclose
Beth A. Coleman, RN, MSN, CPNP-PC, no relevant financial or commercial relationships to disclose
Arlene G. Schiro, MA, ACNP-BC, no relevant financial or commercial relationships to disclose
Janet M. Pinson, NP, no relevant financial or commercial relationships to disclose
Steve Walker, MS, CRNP, indicates that the session may include discussion of FDA off label, investigational or experimental drug use.
Traci Housten, RN, MS, indicates that the session may include discussion of FDA off label, investigational or experimental drug use.
Diahann K. Wilcox, APRN, indicates that the session may include discussion of FDA off label, investigational or experimental drug use.

Disclaimer

The opinions expressed in this program should not be construed as those of the CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
No portion of this activity may be reproduced without the expressed written consent of PHA.

Estimated Time to Complete This Activity

3 hours

Privacy Policy

For information about the PHA's privacy policy, visit http://www.phassociation.org/privacypolicy
This activity is made possible through unrestricted educational grants from Actelion, Gilead, and United Therapeutics.
©2012 Pulmonary Hypertension Association, 801 Roeder Road, Suite 1000, Silver Spring, MD 21910.

Audience

This course is intended for allied health professionals involved in the treatment of pulmonary hypertension patients

Technical Requirements

Web Browser: For optimal viewing, please use Mozilla Firefox or Safari



Take this Course